2020, Number 2
<< Back Next >>
Arch Neurocien 2020; 25 (2)
Myotonic disorders. Systematic review of physical aspects and response to exercise
Brea-Folgar A, Taboada-Iglesias Y
Language: Spanish
References: 31
Page: 19-33
PDF size: 455.85 Kb.
ABSTRACT
Introduction: Myotonic disorders are neuromuscular diseases that present myotonia
as the main symptom and, depending on the affectation, certain activities of daily life
can be compromised. Patients with this symptom often complain of stiffness that may
worsen with cold or fatigue, but some studies claim that this symptomatology improves
with repeated muscle activation. Therefore, the objective of the study was to analyze the
physical characteristics, as well as their response to the exercise of the inherited TM.
Development: In the month of December 2018 a systematic search was carried out in
the PubMed, Medline, Scopus and Cinahl databases. A total of 15 articles were obtained
after applying the selection criteria divided into three sections: assessment of physical
and functional abilities, assessment of myotonia and effect of exercise programs.
Conclusion: The main affectation that was found in TM is in strength, but balance, gait
and performance were also altered. Likewise, moderate and habitual exercise helps
improve physical abilities, providing a better quality of life. However, more studies
of high methodological quality are needed to verify these findings and to better
understand which type of exercises are the most suitable for the different acquisitions.
REFERENCES
Trip J, Drost GG, van Engelen BG, Faber CG. Drug treatment for myotonia. Cochrane Neuromuscular Group, editor. Cochrane Database Syst Rev. 2006;1:CD004762. Doi:10.1002/14651858.CD004762.pub2
Miller TM. Differential diagnosis of myotonic disorders. Muscle Nerve 2008;37(3):293-9. DOI: 10.1002/mus.20923
Lowrie M, Garosi L. Classification of Involuntary Movements in Dogs: Myoclonus and Myotonia. J Vet Intern Med 2017; 31(4):979-87. doi: 10.1111/jvim.14771
Abad-Alegría P, González-Matilla P, Adelantado-Agustí S. Diagnóstico de miotonía clínicamente inesperado. Rev Neurol. 1996; 24(127):276-277.
Kierkegaard M, Harms-Ringdahl K, Edström L, Widén Holmqvist L, Tollbäck A. Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: A randomized controlled pilot study. J Rehabil Med. 2011;43(8):695-702. DOI: 10.2340/16501977-0833
Ørngreen MC, Olsen DB, Vissing J. Aerobic training in patients with myotonic dystrophy type 1. Ann Neurol 2005;57(5):754-7. DOI: 10.1002/ana.20460
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17(1):1-12. DOI: 10.1016/0197-2456(95)00134-4
Hammarén E, Kjellby-Wendt G, Kowalski J, Lindberg C. Factors of importance for dynamic balance impairment and frequency of falls in individuals with myotonic dystrophy type 1 – A cross-sectional study – Including reference values of Timed Up & Go, 10m walk and step test. Neuromuscul Disord 2014;24(3):207-15. DOI: 10.1016/j. nmd.2013.12.003
Hammarén E, Kjellby-Wendt G, Lindberg C. Muscle force, balance and falls in muscular impaired individuals with myotonic dystrophy type 1: A five-year prospective cohort study. Neuromuscul Disord 2015;25(2):141-8. DOI: 10.1016/j.nmd.2014.11.004
Bachasson D, Moraux A, Ollivier G, Decostre V, Ledoux I, Gidaro T, et al. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1. Neuromuscul Disord 2016;26(7):428-35. DOI: 10.1016/j.nmd.2016.05.009
Solbakken G, Ørstavik K, Hagen T, Dietrichs E, Naerland T. Major involvement of trunk muscles in myotonic dystrophy type 1. Acta Neurol Scand 2016;134(6):467-73. DOI: 10.1111/ane.12565
Pucillo EM, Dibella DL, Hung M, Bounsanga J, Crockett B, Dixon M, et al. Physical function and mobility in children with congenital myotonic dystrophy: Physical Function in CDM. Muscle Nerve 2017;56(2):224-9. doi: 10.1002/ mus.25482
Kroksmark A-K, Stridh M-L, Ekström A-B. Long-term follow-up of motor function and muscle strength in the congenital and childhood forms of myotonic dystrophy type 1. Neuromuscul Disord 2017;27(9):826-35. DOI: 10.1016/j.nmd.2017.05.018
Hayes HA, Dibella D, Crockett R, Dixon M, Butterfield RJ, Johnson NE. Stepping Activity in Children With Congenital Myotonic Dystrophy: Pediatr Phys Ther 2018; 30(4):335-9. DOI: 10.1097/pep.0000000000000537
Gawel M, Szmidt-Salkowska E, Lusakowska A, Nojszewska M, Sulek A, Krysa W, et al. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 AND DM2): Value of SET and SETC Tests in DM. Muscle Nerve 2014;49(2):277-83. DOI: 10.1002/mus.23908
Alejo-González MR, Escobar-Cedillo ME, Hernández-Valadez N, Miranda-Duarte A, Arriaga-Rivera J, Santana Díaz L. Aplicación del test electrofisiológico de ejercicio en pacientes con miotonía congénita. Acta Pediatr Esp 2016;74(2):50-6.
Esposito F, Cè E, Rampichini S, Limonta E, Venturelli M, Monti E, et al. Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1. Neuromuscul Disord 2016;26(1):60-72. DOI: 10.1016/j.nmd.2015.09.013
Esposito F, Cè E, Rampichini S, Monti E, Limonta E, Fossati B, et al. Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1. Eur J Appl Physiol 2017;117(3):551-66. DOI: 10.1007/s00421-017-3558-4
Toth A, Lovadi E, Komoly S, Schwarcz A, Orsi G, Perlaki G, et al. Cortical involvement during myotonia in myotonic dystrophy: an fMRI study. Acta Neurol Scand 2015;132(1):65-72. DOI: 10.1111/ane.12360
Brady LI, MacNeil LG, Tarnopolsky MA. Impact of Habitual Exercise on the Strength of Individuals with Myotonic Dystrophy Type 1: Am J Phys Med Rehabil 2014;93(9):739-50. DOI: 10.1097/PHM.0000000000000088
Cudia P, Weis L, Baba A, Kiper P, Marcante A, Rossi S, et al. Effects of Functional Electrical Stimulation Lower Extremity Training in Myotonic Dystrophy Type I: A Pilot Controlled Study. Am J Phys Med Rehabil 2016;95(11):809- 17. DOI: 10.1097/PHM.0000000000000497
Andersen G, Løkken N, Vissing J. Aerobic training in myotonia congenita: Effect on myotonia and fitness: Training and Myotonia. Muscle Nerve 2017;56(4):696-9. DOI: 10.1002/mus.25549
Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F, et al. Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study. PLoS One 2016;11(2):e0148264. DOI: 10.1371/journal.pone.0148264
Mathieu J, Boivin H, Richards CL. Quantitative Motor Assessment in Myotonic Dystrophy. Can J Neurol Sci J Can Sci Neurol 2003;30(02):129-36. DOI: 10.1017/s0317167100053397
Wiles CM. Falls and stumbles in myotonic dystrophy. J Neurol Neurosurg Psychiatry 2005;77(3):393-6. doi: 10.1136/ jnnp.2005.066258
Udd B Krahe R. The myotonic dystrophies: molecular,clinical,and therapeutic challenges. Lancet Neurol 2012;11(10):891-905. DOI: 10.1016/S1474-4422(12)70204-1
Thornton CA. Myotonic Dystrophy. Neurol Clin. agosto de 2014;32(3):705-19. DOI: 10.1016/j.ncl.2014.04.011
Sander HW, Tavoulareas GP, Quinto CM, Menkes DL, Chokroverty S, Menkes DM. The exercise test distinguishes proximal myotonic myopathy from myotonic dystrophy. Muscle Nerve 1997;20(2):235-7. DOI: 10.1002/ (sici)1097-4598(199702)20:2<235::aid-mus17>3.0.co;2-1
Michel P, Sternberg D, Jeannet P-Y, Dunand M, Thonney F, Kress W, et al. Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders. Muscle Nerve 2007;36(5):643-50 DOI: 10.1002/mus.20856.
Zapata-Wainberg G, Sacristana MG de la, Vivancos J. Canalopatías del músculo esquelético de base genética: parálisis periódicas y miotonías no distróficas. Med - Programa Form Médica Contin Acreditado 2015;11(75):4511-5.
Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC. Strength training and aerobic exercise training for muscle disease. Cochrane Neuromuscular Group, editor. Cochrane Database Syst Rev 2013;7:CD003907. Doi: 10.1002/14651858.CD003907.pub4